Push for obesity drug coverage hits major roadblock
Drugmakers have strong opinions about the decision.
Few medications have made the kind of dramatic entrance to the public sphere that semaglutide (GLP-1) and tirzepatide (GIP) have, at least in the last 75-100 years.
First, there was penicillin. Then there was insulin and the birth control pill.
And now there is Ozempic.
"I've said this before, but as more data comes in I become more convinced that we may look back on these drugs as the greatest medical breakthrough of the 21st century. I'm serious." That was a statement Clinical and Translational Research Accelerator at Yale, F. Perry Wilson, MD, MSCE.
